October 12, 2012

Early Study Looks Promising for MS-Like Illness

By Kelley Luckstein

Mayo Clinic researchers say they were surprised by the success of an early study of a drug to treat a disease often misdiagnosed as multiple sclerosis. "It is very impressive, the results so far,'" said Dr. Sean Pittock, co-director of the clinic's neuroimmunology laboratory. But he cautions the study is preliminary and needs confirmation, bigger numbers and a comparison group.

Additional coverage: DailyFinance, FiercePharma, Hartford Business, American News Report


Post-Bulletin by Jeff Hansel

Tags: Dr. Sean Pittock, drug study, multiple sclerosis, neuroimmunology, Post Bulletin, Research

Please sign in or register to post a reply.
Contact Us · Privacy Policy